The increasing number of geriatric population, and occurrences of infectious diseases like cancer, and hepatitis is expected to boost the global immunodiagnostics market. According to a report published by Fortune Business Insights, titled “Immunodiagnostics: Global Market Analysis, Insights, and Forecast, 2018-2025,” the market was valued at US$ 15,777.5 Mn in 2017. Fortune Business Insights predicts that the market will rise at a CAGR of 4.7%, and reach US$ 22,732.7 Mn by the end of 2025.
Oncology and Endocrinology Segment Will Witness Increasing Demand
The immunodiagnostic market is categorized into oncology and endocrinology, infectious disease testing, hepatitis and retrovirus testing, and GI stool testing in terms of application. In 2017, oncology, and endocrinology segment had generated a market share of 25.6%. The segment’s highest share is accredited to the embracing of immunodiagnostics in various applications, namely endocrine diseases and cancer. There has been an increase in the number of reimbursement of products as well as new product approvals. Also, several tests are predicted to propel the global immunodiagnostics market by the end of 2025.
Segmentation
By Product
- Instruments
- Reagents & Consumables
By Application
- Oncology & Endocrinology
- Hepatitis & Retrovirus
- Cardiac Markers
- Infectious Diseases
- Others
By End user
- Clinical Laboratories
- Hospitals
- Physician’s Offices
- Others
By Geography
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Request Sample PDF@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunodiagnostics-market-100444
Abbott, DiaSorin, and Roche Diagnostics are Likely to Hold Significant Share in the Market
Prominent organizations such as Abbott, DiaSorin, and Roche Diagnostics are projected to lead the global immunodiagnostics market during the forecast period. Development strategies, rise in the investments in research and development, cost management, and strong supply chain network are predicted to give impetus to these companies and enable them gain a competitive edge.
Some of the leading companies that are operating in the global immunodiagnostics market are Abbott, Hoffmann-La Roche AG (Roche Diagnostics), DiaSorin, Danaher Corporation, QIAGEN, bioMérieux, Thermo Fisher Scientific, and Quest Diagnostics.
Table Of Content
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Technological Advancements
4.2 Key Industry Developments -Mergers, Acquisitions and Partnerships
4.3 Reimbursement Scenario
4.4 Key Performance Indicators for Global Immunodiagnostics Market
5. Global Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1 Instruments
5.2.2 Reagents & Consumables
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1 Oncology& Endocrinology
5.3.2 Hepatitis & Retrovirus
5.3.3 Cardiac Markers
5.3.4 Infectious Diseases
5.3.5 Others
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1 Clinical Laboratories
5.4.2 Hospitals
5.4.3 Physician’s Offices
5.4.4 Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1 North America
5.5.2 Europe
5.5.3 Asia Pacific
5.5.4 Latin America
5.5.5 Middle East & Africa
6. North America Immunodiagnostics Market Analysis, Insights and Forecast, 2014-2025
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product
6.2.1 Instruments
6.2.2 Reagents & Consumables
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1 Oncology& Endocrinology
6.3.2 Hepatitis & Retrovirus
6.3.3 Cardiac Markers
6.3.4 Infectious Diseases
6.3.5 Others
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1 Clinical Laboratories
6.4.2 Hospitals
6.4.3 Physician’s Offices
6.4.4 Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1 USA
6.5.2 Canada
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/100444
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.